ESC Premium Access

Lipoprotein(a): an emerging lipid risk factor – discussion.

Congress Session

3 more presentations in this session

Lipoprotein(a) and cardiovascular risk.

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Thumbnail

Current treatment for elevated lipoprotein(a).

Speaker: Professor A. Goldberg (Saint Louis, US)

Thumbnail

Future treatments for lipoprotein(a).

Speaker: Professor S. Nicholls (Melbourne, AU)

Thumbnail

Access the full session

Lipoprotein(a): an emerging lipid risk factor

Speakers: Professor B. Nordestgaard, Professor A. Goldberg, Professor S. Nicholls
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACNAP Premium Access

Discussion: Shared decision-making: how, what, and why.

23 May 2022

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC Premium Access

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

27 August 2021

This platform is supported by

logo Novo Nordisk